IEM AND NMB FORGE STRATEGIC PARTNERSHIP TO ADVANCE ENGINEERING INNOVATION, EMERGING TECHNOLOGIES AND SUSTAINABLE DEVELOPMENT

KUALA LUMPUR, Sept 25 (Bernama) -- NMB (NanoMalaysia Berhad), a company limited by guarantee under the Ministry of Science, Technology and Innovation (MOSTI), today exchanged a Memorandum of Understanding (MoU) with The Institution of Engineers, Malaysia (IEM) at the ENGINEER & MARVEX 2026 Exhibition, marking a strategic partnership to strengthen collaboration between the engineering profession and Malaysia's technology commercialisation ecosystem.

This collaboration brings together IEM’s engineering expertise and professional network with NMB’s experience in technology commercialisation and industrial development. Together, we aim to create impactful programmes that bridge innovation and industry needs while supporting Malaysia's transition towards a knowledge-based and sustainable and innovation-driven economy, in line with IEM's IMPACT 2030 vision.

Through the MoU, IEM and NMB will undertake joint initiatives in research, consultancy, technology deployment, standards development, professional competency enhancement, industry engagement, knowledge sharing, and talent development. The partnership will also facilitate collaborations in areas such as advanced materials, digital technologies, Industry 2.0, renewable energy, hydrogen, and other strategic technology sectors such as battery technology and industry localisation.

Prof. (Adj.) Dr. Rezal Khairi Ahmad, Chief Executive Officer of NMB Group, said: "NMB is committed to accelerating the commercialisation of advanced technologies and delivering industry-ready solutions that contribute to national development. Through this partnership with IEM, we will strengthen collaboration among industry, academia, government and professional practitioners to drive innovation-led growth and enhance Malaysia's technological capabilities."

Meanwhile, Ir. Yau Chau Fong, President of IEM, said: "This collaboration brings together IEM's extensive engineering expertise and professional network with NMB's experience in technology commercialisation and industrial development. Together, we aim to create impactful programmes that bridge innovation and industry needs while supporting Malaysia's transition towards a knowledge-based and sustainable economy."

The partnership also recognises IEM's role as a neutral professional platform that brings together government agencies, regulators, industry players, academia and professional bodies to facilitate technical dialogue, consensus-building and the development of engineering standards and competencies for emerging technologies.

The MoU, which is valid for an initial period of three years, is expected to catalyse high-impact programmes that support knowledge transfer, workforce development, technology adoption and greater industry-academia-government collaboration. 

ABOUT NMB
NMB (NanoMalaysia Berhad) was incorporated in 2011 as a company limited by guarantee (CLBG) under the Ministry of Science, Technology and Innovation (MOSTI) to act as a business entity entrusted with nanotechnology commercialisation and industrialisation activities through the NanoMalaysia Venture Builder model. NMB is entrusted with driving nanotechnology development, advancing local EV component technology, and spearheading the hydrogen economy in Malaysia.

ABOUT THE INSTITUTION OF ENGINEERS, MALAYSIA (IEM)

Established in 1959, the Institution of Engineers, Malaysia is the premier learned society for the engineering profession in Malaysia. IEM promotes and advances the science and profession of engineering while facilitating the exchange of technical knowledge and professional expertise among engineers and stakeholders.

SOURCE: NMB (NanoMalaysia Berhad) 

FOR MORE INFORMATION, PLEASE CONTACT: 
Email: corporateaffairs@nanomalaysia.com.my

--BERNAMA

PRODUCTLIFE GROUP UNIFIES UNDER ONE IDENTITY WITH HUMAN, DIGITAL CAPABILITIES

 

KUALA LUMPUR, Sept 30 (Bernama) -- ProductLife Group (PLG) has completed a multi-year transformation, uniting the 26 businesses it has acquired over six years into a single group with an end-to-end set of digital and human capabilities across life sciences.

Full integration across the group is targeted for completion by the end of 2027, according to PLG in a statement.

The transformation reflects an evolution in the way PLG works by combining deep human expertise with intelligent automation, while ensuring every recommendation remains owned by a senior life sciences expert.

It is underpinned by a vision to be the leading global life sciences advanced intelligence business, combining human expertise with intelligent automation to help clients bring new medicines to patients, cure diseases and improve lives.

To deliver on this mission and meet the full range of client needs, PLG is structured around four connected business units, namely Product Development & Engineering, Market & Patient Access, Product Compliance, and Digital & Innovation.

Product Development & Engineering covers activities from molecule to manufacturing, integrating pre-clinical, clinical, chemistry, manufacturing and controls (CMC), and regulatory development with engineering. Market & Patient Access covers market access, health technology assessment (HTA), pricing, health economics and patient-centred evidence.

Meanwhile, Product Compliance covers regulatory affairs, safety and vigilance, and quality assurance; and Digital & Innovation focuses on technology-agnostic digital transformation and artificial intelligence-enabled solutions connecting research and development, quality, manufacturing and commercial operations.

The new logo gives the company's mission a visual form, with its symbol depicting a unified force coming together and advancing upwards and forwards. It represents the collective energy that now connects PLG's four Business Units into one accountable partner.

Under the new identity, PLG said it serves more than 2,000 clients across life sciences through 1,750 experts representing 60 nationalities, with its own operations in over 50 countries and reach into more than 150 countries through its partner network.

-- BERNAMA

i2i Logic Launches 'i2i Banker Fred', An AI-Powered Teammate for Wholesale Bankers

The new AI enabled system identifies, prioritizes and sizes opportunities in wholesale banking – and then activates the banker with all they need to win the deal with their clients.

NEW YORK, Sept 25 (Bernama-BUSINESS WIRE) -- i2i Logic today announced the launch of Banker Fred, its AI-powered teammate for bankers across wholesale banking.

Assessing public and private data, Banker Fred spots opportunities bankers may have missed. He builds a complete picture of a company — its operating profile, industry benchmarks, filings, reports, and bank-proprietary data — then delivers a prioritized, wallet-sized list of exactly where to focus next. Banker Fred then hands the banker a playbook with everything needed to activate the opportunity: reach-out emails, a conversation guide, objection-handling tips, key questions to ask, and a pitch report for the client. The result - bankers who see more clients, more often, and who are far more effective once they're in the room. Banker Fred is the only AI-enabled system designed by and for bankers in corporate, commercial, and transaction banking.

Banker Fred is being made available on a priority basis to i2i Logic's existing commercial partners, including banks across Europe, the US, APAC, and the Middle East. Broader availability is expected during the fourth quarter of 2026.

"Within i2i Logic, we have decades of experience across wholesale banking markets," said Tim Maddock, Co-Founder of i2i Logic. "We've spent the last 10 months cloning our collective expertise into Banker Fred, making him ready to scale across both coverage and product teams. Our design approach is simple: if you can effectively identify the banking needs of your clients and then effectively activate your bankers in front of the C-Suite, your bank will win. We distilled that into Banker Fred. He isn't a machine waiting to be prompted — he does all the analysis and go-to-market support in a single click. Early market testing has been outstanding."

About i2i Logic

The i2i Logic Client Intelligence Platform is used by banks to generate intelligence on corporate client needs – it links those needs to bank solutions in a workflow for the banker and provides supporting material in seconds. Bankers can see more clients more often; clients receive hyper personalized attention. i2i Logic has established offices in Melbourne, New York, London and Hong Kong.

View source version on businesswire.com:
https://www.businesswire.com/news/home/20260921570255/en/ 

Contact

Contact i2i Logic at info@i2ilogic.com
Additional information may be found at www.i2ilogic.com
LinkedIn: https://www.linkedin.com/company/i2ilogic 

Source : i2i Logic

--BERNAMA 

Bitget's Multi-Asset KCGI 2026 Draws More Than 83,000 Traders

VICTORIA, Seychelles, Sept 25 (Bernama-GLOBE NEWSWIRE) -- Bitget, the world's largest Universal Exchange (UEX), has concluded the 2026 King's Cup Global Invitational (KCGI), with more than 83,000 traders across 320 teams taking part in the competition from September 9 to 22. For the first time, KCGI expanded beyond crypto into a multi-asset arena spanning crypto futures, TradFi perpetuals and tokenized U.S. stocks, with a total promotion pool of up to 3 million USDT.

This year's KCGI put Bitget's Universal Exchange model into a live competitive setting. Within the UEX Arena team battle, traders competed across Crypto Futures, TradFi Perps covering stocks, commodities and precious metals, and rToken spot markets for tokenized US equities. Separate trading-volume leaderboards tracked activity across each market, while team PnL determined performance on the overall UEX Arena leaderboard. The UEX Treasure Map extended the competition to CFD trading.

Across the three market-specific leaderboards, Jimmy米哥 100u 翻100倍 ranked first in Crypto Futures trading volume with 1.6 billion, IncomeTips24 led TradFi Perps with 150 million, while rtoken冲击第一队 topped rToken spot trading with 42.5 million.

“KCGI has always been where traders come to prove themselves, but this year we gave them a much bigger arena,” said Gracy Chen, CEO of Bitget. “Crypto, stocks, gold and other markets were all in play, so traders had more opportunities and more decisions to make. That made the competition harder, and much closer to how people actually trade today. Eight years into Bitget, that’s what ‘Built for Perfect Trades’ means to me: keep expanding what traders can do, then let them show us what’s possible.”

KCGI 2026 featured a total promotion pool of up to 3 million USDT, spanning the UEX Arena alongside the UEX Treasure Map, captain rewards, early-bird rewards and a livestream giveaway. The expanded format attracted traders from markets including CIS, Latin American and Southeast Asia, turning the competition into a global test of strategies across different asset classes and market conditions.

The 2026 edition marks the latest evolution of KCGI as Bitget expands its trading ecosystem beyond crypto. Under the theme “Global Alpha in One,” the competition reflected a broader shift in how traders are approaching markets, with crypto, tokenized equities and traditional assets increasingly accessible through the same trading environment.

To see all the winners of KCGI 2025, visit here.

About Bitget

Bitget is the world's largest Universal Exchange (UEX), serving over 125 million users and offering access to over 2M crypto tokens, 500+ tokenized stocks, ETFs, commodities, FX, and precious metals such as gold. The ecosystem is committed to helping users trade smarter with its AI agent, which co-pilots trade execution. Bitget is driving crypto adoption through strategic partnerships such as MotoGP™. Aligned with its global impact strategy, Bitget has joined hands with UNICEF to support blockchain education for 1.1 million people by 2027. Bitget currently leads in the tokenized TradFi market, providing the industry's lowest fees and highest liquidity across 150 regions worldwide.

For more information, visit: Website | X | Telegram | LinkedIn | Discord

For media inquiries, please contact: media@bitget.com 

Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to our Terms of Use.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/92e5189e-0e55-47b3-88fa-0cd207a82fd3 

SOURCE: Bitget Limited

DISCLAIMER: BERNAMA MREM are not accountable for any causes of website defacement, misuse, or illegal activities connected to cryptocurrency, blockchain, tokenisation, or bitcoin. This material should not be considered as guidance or an opinion, as it does not constitute financial or investment advice. Use this information at your own risk; we are not liable for any losses or damages caused by the republication of this article.

Medisca Melancarkan Divisyen Peptida Global

Divisyen baharu membawakan peptida gred API dan kepakaran farmaseutikal Medisca yang mengutamakan kualiti kepada bidang perubatan diperibadikan yang berkembang pesat

MONTREAL, 21 Sept (Bernama-BUSINESS WIRE) -- Medisca hari ini mengumumkan pelancaran Medisca Peptides, sebuah divisyen global khusus yang memberi tumpuan kepada peluasan akses kepada peptida gred API serta pembangunan platform peptida bersepadu untuk pasaran farmaseutikal dan perubatan diperibadikan di seluruh dunia. Seiring dengan perkembangan landskap peptida, Medisca secara proaktif membangunkan keupayaan dan infrastruktur yang diperlukan untuk menyokong peptida gred API dalam rangka kerja kawal selia yang berkenaan.

Pelancaran ini mencerminkan komitmen jangka panjang yang signifikan terhadap peptida, termasuk peluasan portfolio Medisca, hubungan strategik dengan pengeluar serta infrastruktur farmaseutikal yang diperlukan untuk menyokong pertumbuhan kategori ini. Ia turut mencerminkan cita-cita Medisca untuk menjadi peneraju dalam inovasi peptida generasi akan datang.

Bagi Medisca, peluang ini bukanlah sesuatu yang asing.

Lebih 35 tahun lalu, syarikat ini diasaskan untuk membantu merapatkan jurang antara piawaian farmaseutikal yang diperlukan oleh pengamal pengkompaunan dengan ramuan berkualiti yang mudah mereka peroleh. Kini, apabila peptida muncul sebagai bidang penting dalam inovasi farmaseutikal dan perubatan diperibadikan, Medisca melihat satu lagi detik penting bagi industri; detik apabila kualiti, tanggungjawab kawal selia dan akses yang bertanggungjawab akan menjadi faktor kritikal kepada masa depan kategori ini.

Kategori ini sedang berkembang. Medisca berhasrat untuk membantu menetapkan piawaiannya.

“Ketika saya mengasaskan Medisca, saya melihat peluang untuk mendekatkan pengkompaunan farmaseutikal kepada piawaian farmaseutikal tradisional dengan memberikan pengamal pengkompaunan akses yang lebih baik kepada ramuan gred API serta menetapkan piawaian yang lebih tinggi untuk ramuan tersebut,” kata Antonio Dos Santos, Pengasas dan Ketua Pegawai Eksekutif Medisca. “Hari ini, saya melihat peluang yang serupa dalam bidang peptida. Kami tidak memasuki bidang ini sekadar untuk mengikut arus. Kami berhasrat untuk membantu membentuk hala tujunya.”

Menetapkan Piawaian Lebih Tinggi untuk Kualiti Peptida

Pendekatan Medisca bermula dari sumbernya. Syarikat telah memilih rakan kongsi pengilangan yang mantap dan berkongsi pemikiran yang mengutamakan kualiti, dengan memberi keutamaan kepada pengalaman farmaseutikal, sistem kualiti yang terbukti, kepakaran pengilangan serta amalan kualiti dan pematuhan yang kukuh.

Medisca akan menggunakan proses yang telah ditetapkan untuk kelayakan pengilang, pengujian produk, dokumentasi dan pengawasan rantaian bekalan terhadap API peptida yang dibawanya ke pasaran. Kawalan ini amat penting bagi peptida, kerana kerumitan pengilangan, pencirian, ketulenan dan kekotoran berkaitan peptida menimbulkan pertimbangan kualiti yang tersendiri. Medisca komited untuk beroperasi dalam rangka kerja kawal selia yang berkenaan serta menyokong akses yang bertanggungjawab kepada API peptida.

Membangunkan Platform Peptida Bersepadu

Medisca Peptides melangkaui pembekalan API dengan menghimpunkan kepakaran formulasi, teknologi dan peralatan pengkompaunan, perkhidmatan analisis, pendidikan serta sokongan teknikal.

Dengan menghubungkan keupayaan ini dalam satu platform, Medisca menyasarkan untuk menyokong profesional penjagaan kesihatan dan rakan kongsi farmaseutikal dengan ramuan serta kepakaran yang diperlukan untuk mengharungi landskap peptida yang terus berkembang.

“Profesional penjagaan kesihatan dan rakan kongsi farmaseutikal perlu yakin terhadap kualiti dan sumber sesuatu API peptida, tetapi mereka juga memerlukan kepakaran dan infrastruktur untuk melaksanakan inovasi dalam amalan,” kata Charlie Guerini, Ketua Pegawai Komersial Medisca. “Itulah yang sedang kami bangunkan menerusi Medisca Peptides: sebuah platform bersepadu yang menghimpunkan portfolio API yang semakin berkembang, rakan kongsi pengilangan yang dipilih dengan teliti, bekalan yang boleh dipercayai serta kepakaran teknikal yang telah dipercayai pelanggan kami selama berdekad-dekad.”

Membentuk Masa Depan Inovasi Peptida

Pelancaran ini menandakan permulaan strategi yang lebih luas dan merangkumi tempoh beberapa tahun untuk menjadikan Medisca sebagai peneraju global dalam kualiti, bekalan dan inovasi peptida.

Medisca akan memperluas portfolio API peptidanya dan hubungan strategik dengan pengilang, sambil melabur dalam keupayaan saintifik, analisis, formulasi, teknikal dan pendidikan yang diperlukan untuk memajukan peluang merentas bidang farmaseutikal dan perubatan diperibadikan.

Melangkaui aspek pembekalan, Medisca akan memainkan peranan kepimpinan yang aktif dalam membentuk masa depan peptida, dengan menggalakkan perlindungan tambahan, ketelusan, akses yang bertanggungjawab dan piawaian kualiti yang sewajarnya, sambil bekerjasama dengan pengilang, profesional penjagaan kesihatan serta pihak berkepentingan industri seiring perkembangan sains, peraturan dan amalan klinikal.

Cita-citanya jelas: membantu membentuk generasi peptida seterusnya dengan menghimpunkan kualiti, kepakaran dan penyelesaian bersepadu yang diperlukan untuk memajukan kategori ini.

Medisca Peptides akan mula dilancarkan secara berperingkat di pasaran global terpilih, dengan pengumuman tambahan berkaitan portfolio, perkongsian strategik dan keupayaan akan menyusul.

Maklumat tentang Medisca

Ditubuhkan pada tahun 1989, Medisca ialah peneraju dalam perubatan diperibadikan dan penyelesaian rantaian bekalan farmaseutikal, dengan portfolio luas yang merangkumi lebih 2,000 produk, dilengkapi pustaka lebih 10,000 formula ubat proprietari dan tersuai, serta kepakaran dan perkhidmatan dalam pengkompaunan farmaseutikal, pendidikan penjagaan kesihatan berterusan dan pengujian analisis. Dengan menyediakan penyeleswww.medisca.com dan ikuti kami diaian yang disesuaikan secara teliti untuk pelbagai sektor kesejahteraan di banyak pasaran di seluruh dunia, Medisca merapatkan jurang dalam penjagaan kesihatan dan memperkasa kesejahteraan diperibadikan untuk semua. Untuk maklumat lanjut, sila layari www.medisca.com dan ikuti kami di LinkedIn, Facebook dan YouTube.

Teks bahasa sumber asal pengumuman ini adalah versi rasmi yang sahih. Terjemahan yang disediakan hanya sebagai penyesuaian sahaja, dan hendaklah di silang-rujuk dengan teks bahasa sumber, yang satu-satunya versi teks dengan kesan undang-undang.

Contacts

Medisca Communications
communications@medisca.com
1-800-665-6334
 
Sumber: Medisca

--BERNAMA 

YEAHKA’S YEAHPAY EXPANDS MERCHANT SERVICES TO SEVEN MARKETS

KUALA LUMPUR, Sept 22 (Bernama) -- Yeahka Limited, a payment-based technology platform, announced that its international payment business, YeahPay, is working with Stripe to expand merchant services to seven markets.

Businesses incorporated in Australia, Canada, Hong Kong, Japan, Singapore, the United Kingdom and the United States can now be onboarded by YeahPay for online acquiring in their respective markets, supporting merchants and platforms with integrated online and in-store payment capabilities.

Yeahka in a statement said the expansion further strengthens YeahPay’s online payment infrastructure across key global markets.

“The number of ways to pay is growing faster than any business can integrate them, and the gap only widens from here. New rails, new currencies, and buyers who are not always human.

“Our clients should not have to predict any of it. YeahPay is the single integration a business needs to accept any form of payment, and when the next way to pay arrives, they will already be able to accept it,” said YeahPay Global Vice President, David Tay.

Alongside expanding its international market coverage and payment capabilities, YeahPay is also preparing for the next evolution of commerce by prioritising capabilities around agentic payments, exploring applications across online retail, dining and gaming, and beginning proof-of-concept collaborations with international financial institutions.

As intelligent agents increasingly participate in transactions, YeahPay continues to expand its payment capabilities and help merchants prepare for the next generation of commerce.

Listed on the Hong Kong Stock Exchange in 2020, Yeahka serves approximately 9.2 million merchants and nearly one billion consumers. Its international payment brand, YeahPay, offers secure, seamless and efficient digital financial services to global clients.

-- BERNAMA

ASEAN-KOREA CENTRE OPENS THIRD VENUE IN JEONJU

 

KUALA LUMPUR, Sept 22 (Bernama) -- The ASEAN-Korea Centre (AKC) opened the Jeonju ASEAN Hall at the Korea Traditional Culture Center in Jeonju on Sept 17, marking its third venue following Seoul and Jeju.

The opening event drew around 100 guests, including representatives of the AKC, the ASEAN Committee in Seoul (ACS), Jeonju City, the Ministry of Foreign Affairs, Jeonbuk State, media, and universities.

“The AKC will continue presenting exhibitions and programmes to establish the hall as a venue for ASEAN-Korea cultural exchange across the wider region,” said AKC Secretary General, Kim Jae-shin in a statement.

The Jeonju ASEAN Hall is the Honam region’s first venue for ASEAN-Korea cultural exchange. It expands ASEAN culture and arts beyond the Seoul metropolitan area and serves as a cultural diplomacy platform connecting K-culture and ASEAN culture (A-culture).

Its inaugural exhibition, ASEAN: Where Hands Bridge Time, highlighted the traditional heritage of the 11 ASEAN Member States (AMS) through the theme of hands, with around 70 cultural artefacts displayed, including masks, textiles, musical instruments, and shadow puppets.

During the ceremony, remarks were delivered by Kim, Jeonju Mayor Cho Ji-hun, and Philippine Ambassador Bernadette Therese C. Fernandez, representing the 2026 ASEAN Chair. Director-General for ASEAN and Southeast Asian Affairs Kwon Jae-hwan spoke on behalf of Foreign Minister Cho Hyun.

The celebration featured a pansori performance by the Jeonbuk State Gugak Center, followed by Filipino singer Dorado performing “Golden” from K-Pop Demon Hunters and Cho Yong-pil’s “The Dreams”.

Following the opening, the AKC and Jeonju Cultural Foundation offered the ASEAN Brunch Box and ASEAN Cooking Class. The Hall will expand access to ASEAN culture and boost Jeonju’s international profile as Jeonbuk State pursues its 2036 Olympic bid.

-- BERNAMA